- Home
- ARBB vs BCTX Comparison
ARBB vs BCTX Comparison
Compare ARBB & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBB
- BCTX
- Stock Information
- Founded
- ARBB 1997
- BCTX 2014
- Country
- ARBB Singapore
- BCTX Canada
- Employees
- ARBB 13
- BCTX N/A
- Industry
- ARBB EDP Services
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- ARBB Technology
- BCTX Health Care
- Exchange
- ARBB Nasdaq
- BCTX Nasdaq
- Market Cap
- ARBB 15.9M
- BCTX 16.1M
- IPO Year
- ARBB 2023
- BCTX N/A
- Fundamental
- Price
- ARBB $6.85
- BCTX $3.52
- Analyst Decision
- ARBB
- BCTX Strong Buy
- Analyst Count
- ARBB 0
- BCTX 1
- Target Price
- ARBB N/A
- BCTX $32.00
- AVG Volume (30 Days)
- ARBB 166.6K
- BCTX 793.1K
- Earning Date
- ARBB 06-13-2025
- BCTX 06-13-2025
- Dividend Yield
- ARBB N/A
- BCTX N/A
- EPS Growth
- ARBB N/A
- BCTX N/A
- EPS
- ARBB N/A
- BCTX N/A
- Revenue
- ARBB $24,425,491.00
- BCTX N/A
- Revenue This Year
- ARBB N/A
- BCTX N/A
- Revenue Next Year
- ARBB N/A
- BCTX N/A
- P/E Ratio
- ARBB N/A
- BCTX N/A
- Revenue Growth
- ARBB N/A
- BCTX N/A
- 52 Week Low
- ARBB $0.21
- BCTX $2.81
- 52 Week High
- ARBB $1.24
- BCTX $29.40
- Technical
- Relative Strength Index (RSI)
- ARBB 96.09
- BCTX 46.81
- Support Level
- ARBB $0.46
- BCTX $2.81
- Resistance Level
- ARBB $0.64
- BCTX $3.72
- Average True Range (ATR)
- ARBB 0.10
- BCTX 0.26
- MACD
- ARBB 0.39
- BCTX 0.04
- Stochastic Oscillator
- ARBB 93.08
- BCTX 61.54
About ARBB ARB IOT Group Limited
ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.